Charles H Lang Selected Research

Charles H Lang Research Topics

Disease

38	Sepsis (Septicemia) 01/2023 - 09/2002
13	Atrophy 12/2015 - 12/2005
12	Muscular Atrophy (Muscle Atrophy) 06/2022 - 12/2005
10	Inflammation (Inflammations) 06/2022 - 06/2007
10	Muscular Diseases (Myopathy) 10/2019 - 01/2002
7	Infections 01/2022 - 05/2002
7	Insulin Resistance 01/2016 - 09/2005
5	Peritonitis 11/2016 - 11/2006
5	Resistance To Insulin-Like Growth Factor I 01/2011 - 03/2003
4	Alcoholism (Alcohol Abuse) 07/2016 - 01/2002
4	Body Weight (Weight, Body) 03/2015 - 02/2009
4	Hypertrophy 03/2015 - 07/2007
4	Burns 01/2007 - 01/2002
3	Obesity 07/2016 - 01/2012
3	Atrophic Muscular Disorders 01/2016 - 01/2008
3	Fibrosis (Cirrhosis) 08/2015 - 12/2014
3	Tuberous Sclerosis (Bourneville's Disease) 11/2013 - 10/2008
3	Bacterial Infections (Bacterial Infection) 01/2011 - 06/2009
3	Weight Loss (Weight Reduction) 02/2009 - 12/2004
2	Muscle Weakness 10/2019 - 03/2015
2	Hyperinsulinism (Hyperinsulinemia) 05/2016 - 04/2014
2	Alcoholic Fatty Liver 12/2014 - 01/2002
2	Wounds and Injuries (Trauma) 06/2014 - 11/2003
2	Abscess 12/2006 - 12/2004
1	Binge Drinking 11/2021
1	Myotoxicity 11/2021
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Septic Shock (Toxic Shock Syndrome) 05/2019

Drug/Important Bio-Agent (IBA)

53	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
31	Messenger RNA (mRNA)IBA 12/2018 - 01/2002
25	Insulin-Like Growth Factor I (IGF-1)IBA 12/2015 - 01/2002
21	Muscle Proteins (Muscle Protein)IBA 01/2021 - 01/2002
13	UbiquitinIBA 01/2017 - 12/2005
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 01/2002
12	Leucine (L-Leucine)FDA Link 12/2014 - 10/2004
11	CytokinesIBA 05/2019 - 01/2002
10	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2003
9	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2018 - 12/2005
9	Eukaryotic Initiation Factor-4EIBA 01/2017 - 04/2004
8	TOR Serine-Threonine KinasesIBA 01/2017 - 10/2004
8	Insulin (Novolin)FDA Link 11/2014 - 10/2004
8	Insulin-Like PeptidesIBA 11/2010 - 01/2002
7	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 01/2014 - 10/2004
7	GlucocorticoidsIBA 08/2007 - 01/2002
6	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2017 - 10/2004
6	Ligases (Synthetase)IBA 11/2010 - 12/2005
6	Growth Hormone (Somatotropin)IBA 08/2007 - 05/2002
6	Mifepristone (RU 486)FDA Link 02/2007 - 01/2002
5	Phosphotransferases (Kinase)IBA 01/2017 - 08/2007
5	Peptide Initiation Factors (Initiation Factor)IBA 01/2017 - 12/2006
5	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2007 - 12/2005
4	CorticosteroneIBA 11/2021 - 01/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2014 - 01/2002
4	Ethanol (Ethyl Alcohol)IBA 04/2014 - 01/2002
4	Insulin-Like Growth Factor Binding ProteinsIBA 11/2010 - 01/2002
4	Amino Acids FDA Link 11/2009 - 10/2004
3	Carrier Proteins (Binding Protein)IBA 01/2017 - 09/2002
3	Mechanistic Target of Rapamycin Complex 1IBA 12/2015 - 02/2011
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2014 - 04/2006
3	EndotoxinsIBA 05/2014 - 04/2006
3	LipopolysaccharidesIBA 05/2014 - 01/2002
3	Hormones (Hormone)IBA 05/2014 - 05/2005
3	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 02/2009
3	AcidsIBA 08/2013 - 01/2002
3	Insulin-Like Growth Factor Binding Protein 1IBA 11/2010 - 01/2002
3	Proteasome InhibitorsIBA 01/2008 - 12/2005
3	Bortezomib (Velcade)FDA Link 01/2008 - 12/2005
2	ResistinIBA 01/2022 - 05/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2017
2	Caspase 3 (Caspase-3)IBA 12/2018 - 01/2002
2	AMP-Activated Protein KinasesIBA 01/2017 - 06/2007
2	eIF-4BIBA 01/2017 - 01/2014
2	ZincIBA 01/2017 - 11/2016
2	salicylhydroxamic acid (SHAM)IBA 03/2015 - 01/2015
2	JNK Mitogen-Activated Protein KinasesIBA 04/2014 - 01/2002
2	trans-sodium crocetinate (crocetin)IBA 11/2013 - 10/2008
2	3-methylhistidineIBA 07/2011 - 11/2009
2	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 03/2011 - 04/2004
2	IncretinsIBA 09/2010 - 02/2009
2	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 09/2010 - 02/2009
2	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2010 - 02/2009
2	AICA ribonucleotide (ZMP)IBA 10/2008 - 01/2008
2	Ribosomal Protein S6IBA 02/2008 - 10/2004
2	Tumor Necrosis Factor InhibitorsIBA 02/2005 - 09/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	NeurotoxinsIBA 11/2021
1	DesminIBA 01/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	Contractile ProteinsIBA 01/2021
1	Myosins (Myosin)IBA 01/2021
1	TropomyosinIBA 01/2021
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2021
1	VimentinIBA 01/2021
1	Troponin IIBA 01/2021
1	Caspase 1 (ICE Protease)IBA 12/2018

Therapy/Procedure

15	Punctures 01/2022 - 07/2003
15	Ligation 01/2022 - 07/2003
2	Therapeutics 04/2015 - 05/2014
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 09/2010 - 02/2009
2	Oral Administration 02/2005 - 10/2004